| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/22/2003 | EP1355149A2 Assessing colorectal cancer |
| 10/22/2003 | EP1354962A1 Use of the slug gene or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells |
| 10/22/2003 | EP1354961A1 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 10/22/2003 | EP1354959A1 Process for producing recombinant protein and fused protein |
| 10/22/2003 | EP1354958A1 Preparation and use of DNA-polyelectrolyte nanoparticles for gene transfer |
| 10/22/2003 | EP1354957A1 Process for producing coenzyme q 10 |
| 10/22/2003 | EP1354956A1 Process for producing prenyl alcohol |
| 10/22/2003 | EP1354955A1 Process for producing prenyl alcohol |
| 10/22/2003 | EP1354954A1 Process for producing prenyl alcohol |
| 10/22/2003 | EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases |
| 10/22/2003 | EP1354952A1 Smac-peptides as therapeutics against cancer and autoimmune diseases |
| 10/22/2003 | EP1354951A1 Method of examining ability to control nerve cell plasticity |
| 10/22/2003 | EP1354950A1 Nf-kb activating gene |
| 10/22/2003 | EP1354949A1 Human fgf23 protein mutant lowering blood phosphorus level |
| 10/22/2003 | EP1354948A1 Novel cancer-associated genes |
| 10/22/2003 | EP1354946A1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 10/22/2003 | EP1354945A1 Method of identifying within a mammala dna encoding physiologically active polypeptide |
| 10/22/2003 | EP1354942A1 Induction of insulin-producing cells |
| 10/22/2003 | EP1354893A2 Physiologically active complex |
| 10/22/2003 | EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein |
| 10/22/2003 | EP1354889A1 Trasncription activation complex and utilization thereof |
| 10/22/2003 | EP1354598A2 Therapeutic uses of BR43X2 soluble receptors |
| 10/22/2003 | EP1354204A2 Hcv antigen/antibody combination assay |
| 10/22/2003 | EP1354199A2 Diagnosis and treatment of multiple sclerosis |
| 10/22/2003 | EP1354192A2 Multi-channel bio-separation cartridge |
| 10/22/2003 | EP1354065A2 High through-put cloning of protooncogenes |
| 10/22/2003 | EP1354063A2 Detecting specific nucleotide sequences |
| 10/22/2003 | EP1354062A2 Target activated nucleic acid biosensor and methods of using same |
| 10/22/2003 | EP1354061A2 Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits |
| 10/22/2003 | EP1354059A1 Method for detecting whether an organism is homozygous or heterozygous using labelled primers and rflp |
| 10/22/2003 | EP1354058A1 Isolation and characterisation of an anther-specific promoter (cofs) in cotton |
| 10/22/2003 | EP1354057A2 Targeted genetic manipulation using mu bacteriophage cleaved donor complex |
| 10/22/2003 | EP1354056A2 Enhanced secretion of a polypeptide by a microorganism |
| 10/22/2003 | EP1354055A1 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 10/22/2003 | EP1354054A2 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
| 10/22/2003 | EP1354053A2 Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof |
| 10/22/2003 | EP1354052A2 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins |
| 10/22/2003 | EP1354051A1 Novel nucleotide sequences that encode the cite gene |
| 10/22/2003 | EP1354050A2 Acyl coenzyme a thioesterases |
| 10/22/2003 | EP1354049A2 16816 and 16839, human phospholipase c molecules and uses therefor |
| 10/22/2003 | EP1354048A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/22/2003 | EP1354047A2 Methods for screening compounds that modulate lipid metabolism |
| 10/22/2003 | EP1354046A2 A member of the lysyl oxidase gene family |
| 10/22/2003 | EP1354045A2 Hyperglycosylated polypeptides |
| 10/22/2003 | EP1354044A1 Nurr1 transcription factor i-box mutants having monomeric transcriptional activation activity |
| 10/22/2003 | EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 10/22/2003 | EP1354042A2 Proteins and nucleic acids encoding same |
| 10/22/2003 | EP1354041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 10/22/2003 | EP1354040A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/22/2003 | EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof |
| 10/22/2003 | EP1354038A2 Double-stranded rna-mediated gene suppression |
| 10/22/2003 | EP1354036A2 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases |
| 10/22/2003 | EP1354035A1 Methods and means for producing efficient silencing construct using recombinational cloning |
| 10/22/2003 | EP1354034A2 Transgenic transchromosomal rodents for making human antibodies |
| 10/22/2003 | EP1354033A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 10/22/2003 | EP1354031A2 Nucleotide incorporating enzymes |
| 10/22/2003 | EP1354029A2 Foggy |
| 10/22/2003 | EP1353956A1 Method for surface display of proteins on genetic carriers |
| 10/22/2003 | EP1353955A2 High affinity antibodies |
| 10/22/2003 | EP1353954A2 Anticoagulants and their uses |
| 10/22/2003 | EP1353953A2 Mu-1, member of the cytokine receptor family |
| 10/22/2003 | EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 10/22/2003 | EP1353951A1 Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof |
| 10/22/2003 | EP1353950A2 Method and apparatus for the production of antigens and uses thereof |
| 10/22/2003 | EP1353949A2 Compositions and methods relating to ovary specific genes and proteins |
| 10/22/2003 | EP1353947A2 Gene expression profiling of primary breast carcinomas using arrays of candidate genes |
| 10/22/2003 | EP1353946A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 10/22/2003 | EP1353945A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 10/22/2003 | EP1353943A1 NOVEL GENE ENCODING AN F-BOX PROTEIN WHICH REGULATES LEAF LONGEVITY IN i ARABIDOPSIS THALIANA /i AND MUTANT GENE THEREOF |
| 10/22/2003 | EP1353941A2 Modified zinc finger binding proteins |
| 10/22/2003 | EP1353937A2 Specific human antibodies for selective cancer therapy |
| 10/22/2003 | EP1353936A2 Primers and methods for the detection and discrimination of nucleic acids |
| 10/22/2003 | EP1353935A2 Selection of catalytic nucleic acids targeted to infectious agents |
| 10/22/2003 | EP1353702A2 Genetic engineering of vascular grafts to resist disease |
| 10/22/2003 | EP1353691A2 Molecular antigen array presenting amyloid beta |
| 10/22/2003 | EP1353688A2 Method and compositions for immunization with the pseudomonas v antigen |
| 10/22/2003 | EP1353687A2 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 10/22/2003 | EP1353683A2 Ghrelin analogs |
| 10/22/2003 | EP1353680A2 Use of slpi for treating chronic inflammatory intestinal diseases |
| 10/22/2003 | EP1353549A2 Mice heterozygous for wfs1 gene as mouse models for depression |
| 10/22/2003 | EP1181371B1 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
| 10/22/2003 | EP1177209B1 Compositions of solvents and high concentrations of nucleic acid analogs |
| 10/22/2003 | EP1003872B1 Increasing production of proteins in gram-positive microorganisms |
| 10/22/2003 | EP1003860B1 Modified dorsal tissue affecting factor and compositions |
| 10/22/2003 | EP0986572B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 10/22/2003 | EP0927270B1 Lyophilization of cultured human cells to preserve rna and dna |
| 10/22/2003 | EP0922059B1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions |
| 10/22/2003 | EP0852620B1 Human jtv1 gene overlaps pms2 gene |
| 10/22/2003 | EP0851927B1 Compounds for immunotherapy and diagnosis of tuberculosis |
| 10/22/2003 | EP0815221B1 A novel growth factor and a genetic sequence encoding same |
| 10/22/2003 | EP0659217B1 CLONING AND EXPRESSION OF beta APP-C100 RECEPTOR |
| 10/22/2003 | EP0658209B1 Endothelial lineage specific transcriptional regulatory element from tek |
| 10/22/2003 | CN1451050A Method for controlling the microbiological guality of an aqueous medium and kit therefor |
| 10/22/2003 | CN1451048A Expression of biologically active polypeptides in duckweed |
| 10/22/2003 | CN1451047A Corynebacterium glutamicum genes encoding stress resistance and tolerance proteins |
| 10/22/2003 | CN1451046A 保守的奈瑟球菌抗原 Conservative Neisseria antigen |
| 10/22/2003 | CN1451045A IFN-alpha homologues |
| 10/22/2003 | CN1451044A Neutrokine-α和Neutrokine-α剪接变体 Neutrokine-α and Neutrokine-α splice variants |
| 10/22/2003 | CN1451043A Dual specificity antibodies and methods of making and using |
| 10/22/2003 | CN1451042A Method of monitoring HIV drug resistance |